Clinical Benefits

Adding tomosynthesis to mammography exams provides clinical advantages for your patients 

  • Breast cancer screening with tomosynthesis detects cancers missed with conventional 2D mammography1
  • Tomosynthesis gives radiologists the confidence to significantly reduce recall rates2
  • Tomosynthesis may reduce biopsy rates. Facilities using tomosynthesis have reported an overall decrease in the number of breast biopsies performed, coupled with a higher rate of positive biopsies11
  • Tomosynthesis is effective in both fatty and dense breasts; however, the impact is greater in dense breasts, which typically contain many overlapping structures3,5

Increased detection—finding cancers earlier

5-year survival rates are nearly 90% when breast cancers are detected early, if cancer has spread to the regional lymph nodes, 5-year survival drops to 80%. 12

Finding cancers that would have been missed by 2D mammography gives patients and their doctors a head start on treatments.

Early detection opens up a wider range of treatment options, such as breast-conserving surgery, which may be less traumatic to the patient.

Dr. Martínez Miravete“After performing 5,700 mammograms with 3D we saw a 33% increase in sensitivity. I have made many more diagnoses than I would with conventional mammography. We are finding smaller lesions in women with dense breasts and implants as well as malignant pathology in younger women that we would not have seen before. These are the lesions we need to find, the ones that can hide, grow and threaten a woman’s life.”

 Dr. Martínez Miravete, Diagnostic Radiology Center, Zaragoza, Spain

Reduced recalls–reduced anxiety

Clinical studies have shown that the use of breast tomosynthesis can reduce recalls by 30% to 40%.2,6

Widespread use of this technology could spare many of women the anxiety and burden associated with the need to undergo additional tests to rule out breast cancer.

Reduced recalls—fewer patients lost to follow-up

Fewer recalls can translate into a reduced burden on doctors and other health care professionals to track and monitor compliance to ensure that all patients referred for recall exams actually follow through.

More time and resources can be focused on ensuring that no patients are lost to follow-up and breast cancer diagnoses are not delayed.

Fewer biopsies—less trauma

Biopsies are necessary to establish a definitive diagnosis of breast cancer; however, even minimally invasive procedures can be traumatic to the patient.

A decrease in the number of biopsies performed, particularly those that result in negative findings, could lead to less anxiety and trauma to patients.13

Breast Biopsy

Undergoing a breast biopsy and waiting for the results can be a very stressful experience for a woman.

print email
Hologic - Contact Us

contact us

Hologic N.V.
Leuvensesteenweg 250A
1800 Vilvoorde
Belgium
Tel: +32.2.711.4680